Matthew Lee
29Patents
8h-index
125Co-inventors
78Inventor score
Filing activity: Jul 1, 2002 → Aug 26, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6974830B2 | NR1H4 nuclear receptor binding compounds | Chemistry; Metallurgy | 32 | Expired |
| US9090593B2 | Bicyclic compounds as Pim inhibitors | Chemistry; Metallurgy | 22 | Active |
| US7652009B2 | Substituted heterocycles and methods of use | Chemistry; Metallurgy | 21 | Active |
| US7034046B2 | NR1H4 nuclear receptor binding compounds | Chemistry; Metallurgy | 19 | Expired |
| US7098336B2 | FXR NR1H4 nuclear receptor binding compounds | Chemistry; Metallurgy | 18 | Expired |
| US7514566B2 | Thiazole compounds and methods of use | Chemistry; Metallurgy | 15 | Active |
| US8088794B2 | Substituted amide derivatives and methods of use | Chemistry; Metallurgy | 10 | Active |
| US7919504B2 | Thiadiazole modulators of PKB | Chemistry; Metallurgy | 10 | Active |
| US8017601B2 | Bis-aryl kinase inhibitors and method | Chemistry; Metallurgy | 7 | Active |
| US7687522B2 | Substituted pyridines and pyrimidines and their use in treatment of cancer | Chemistry; Metallurgy | 7 | Active |
| US10266542B2 | EZH2 inhibitors | Chemistry; Metallurgy | 6 | Active |
| US8685983B2 | Method of treating cancer with substituted amide derivatives | Chemistry; Metallurgy | 5 | Active |
| US11267812B2 | KRAS G12C inhibitors | Chemistry; Metallurgy | 5 | Active |
| US11091495B2 | Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors | Human Necessities | 4 | Active |
| US11220509B2 | Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors | Human Necessities | 2 | Active |
| US7915287B2 | Substituted heterocycles and methods of use | Chemistry; Metallurgy | 1 | Active |
| US11806346B2 | HTT modulators for treating Huntington's disease | Chemistry; Metallurgy | 1 | Active |
| US8084479B2 | Thiazole compounds and methods of use | Chemistry; Metallurgy | 1 | Active |
| US11918662B2 | Heterocyclic compounds and imaging agents for imaging huntingtin protein | Chemistry; Metallurgy | 0 | Active |
| US10745381B2 | Substituted isoquinolines and phthalazines as rock kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11389438B2 | Compounds for targeting mutant huntingtin protein and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11248004B2 | Substituted isoquinolines as rock kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12371435B2 | Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors | Human Necessities | 0 | Active |
| US11932633B2 | KRas G12C inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11485738B2 | Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.